CEO of Atlas Venture & Alnylam Pharmaceuticals
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
Atlas Venture creates and invests in biotech startup companies in the U.S. with seed and early stage venture investments.
Agios Pharmaceuticals is a public American pharmaceutical company